Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A department of veterans affairs cooperative study

O. Clegg, Daniel; J. Reda, Domenic; H. Weisman, Michael; J. Cush, John; B. Vasey, Frank; Ralph Schumacher, H.; Budiman‐Mak, Elly; J. Balestra, Dominic; D. Blackburn, Warren; W. Cannon, Grant; D. Inman, Robert; Paul Alepa, F.; Mejías, Edwin; R. Cohen, Miriam; Makkena, Rama; L. Mahowald, Maren; Higashida, Jean; L. Silverman, Stuart; Parhami, N; N. Buxbaum, Joel; Haakenson, Clair; H. Ward, Richard; Manaster, B.J.; J. Anderson, Robert; Ward, John; G. Henderson, William

doi:10.1002/art.1780391211

Public

Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A department of veterans affairs cooperative study

Published in Arthritis & Rheumatism • Dec 1, 1996

Authors:

Daniel O. Clegg

Domenic J. Reda

Michael H. Weisman

Abstract

OBJECTIVE: To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective in the treatment of reactive arthritis (ReA) that has been unresponsive to nonsteroidal antiinflammatory drug (NSAID) therapy. METHODS: One hundred thirty-four patients with ReA who had failed to respond to ...

Subject

Medicine

Sulfasalazine

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!